SciBase Holding AB | Balance Sheet

Fiscal year is January-December. All values SEK Thousands.
2014
2015
2016
2017
Cash & Short Term Investments
27,566.00
133,736.00
84,955.00
110,015.00
Total Accounts Receivable
1,220.00
2,376.00
2,535.00
2,450.00
Inventories
945.00
5,367.00
4,038.00
4,514.00
Other Current Assets
1,899.00
1,144.00
1,090.00
1,004.00
Total Current Assets
31,630.00
142,623.00
92,618.00
117,983.00
Net Property, Plant & Equipment
8,796.00
9,446.00
8,312.00
8,761.00
Total Investments and Advances
1,185.00
1,182.00
1,176.00
1,168.00
Total Assets
41,611.00
153,251.00
102,106.00
127,912.00
Accounts Payable
2,668.00
3,224.00
3,285.00
1,803.00
Income Tax Payable
843.00
204.00
111.00
-
Other Current Liabilities
4,599.00
4,088.00
5,980.00
10,362.00
Total Current Liabilities
8,110.00
7,516.00
9,376.00
12,165.00
Deferred Taxes
27.00
26.00
25.00
23.00
Other Liabilities
829.00
-
-
-
Total Liabilities
8,966.00
7,542.00
9,401.00
12,188.00
Common Equity (Total)
32,645.00
145,709.00
92,705.00
115,724.00
Total Shareholders' Equity
32,645.00
145,709.00
92,705.00
115,724.00
Total Equity
32,645.00
145,709.00
92,705.00
115,724.00
Liabilities & Shareholders' Equity
41,611.00
153,251.00
102,106.00
127,912.00

About SciBase Holding AB

View Profile
Address
Kammakargatan 22
Stockholm AB 111 40
Sweden
Employees -
Website http://www.scibase.se
Updated 09/14/2018
SciBase Holding AB is a medical technology company, which engages in the development of instruments for the detection of skin cancer and other skin conditions. Its product includes Nevisense, which is a diagnostic support tool for non-visual detection of malignant melanoma. The company was founded by Stig Gösta Ollmar in 1998 and is headquartered in Stockholm, Sweden.